Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats

被引：0
|
作者：
Shizuka Aritomi
Kazumi Niinuma
Tetsuya Ogawa
Tomoyuki Konda
Kosaku Nitta
机构：
[1] Ajinomoto Pharmaceuticals Co.,Research Center
[2] Ltd.,Department of Medicine, Kidney Center
[3] Tokyo Women’s Medical University,Department of Medicine, Medical Center East
[4] Tokyo Women’s Medical University,undefined
来源：
Clinical and Experimental Nephrology | 2013年 / 17卷
关键词：
Cilnidipine; Streptozotocin; Blood pressure; Proteinuria; Renoprotection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：41 / 50
页数：9
相关论文
共 50 条
  • [21] Angiotensin II type 1 receptor genotype and response to angiotensin II receptor blocker valsartan in early stage diabetic nephropathy
    Takei, Kako
    Kimura, Tomomi
    Miyazaki, Mitsuhiro
    Matsumoto, Ryuma
    muramatsu, Masaaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 223 - 223
  • [22] Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats
    Hasegawa, Goji
    Fukui, Michiaki
    Hosoda, Hiroko
    Asano, Mai
    Harusato, Ichiko
    Tanaka, Muhei
    Shiraishi, Emi
    Senmaru, Takashi
    Sakabe, Kazumi
    Yamasaki, Masahiro
    Kitawaki, Jo
    Fujinami, Aya
    Ohta, Mitsuhiro
    Obayashi, Hiroshi
    Nakamura, Naoto
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 605 (1-3) : 164 - 169
  • [23] Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
    Jacobsen, P
    Andersen, S
    Jensen, BR
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (04): : 992 - 999
  • [24] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 601 - 606
  • [25] KRH-594, a new angiotensin AT1 receptor antagonist, ameliorates nephropathy and hyperlipidaemia in diabetic spontaneously hypertensive rats
    Inada, Y
    Murakami, M
    Tazawa, S
    Akahane, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (04): : 270 - 276
  • [26] Interaction between nitric oxide and angiotensin II receptors in a spontaneously hypertensive rat model of diabetic nephropathy
    Wessels, J
    Pussell, BA
    Macdonald, GJ
    JOURNAL OF HYPERTENSION, 1998, 16 : S119 - S119
  • [27] Treatment of diabetic nephropathy with angiotensin II receptor antagonist
    E. J. Lewis
    J. B. Lewis
    Clinical and Experimental Nephrology, 2003, 7 (1) : 0001 - 0008
  • [28] Effect of pioglitazone on vasopressor responses to adrenergic agonists and angiotensin II in diabetic and non-diabetic spontaneously hypertensive rats
    Afzal, Sheryar
    Sattar, Munavvar Abdul
    Akhtar, Safia
    Abdullah, Nor Azizan Binti
    Eseyin, Olorunfemi A.
    Abdulla, Mohammed H.
    Johns, Edward James
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (03) : 747 - 754
  • [29] Angiotensin II receptor antagonism in diabetic nephropathy - Commentary
    Williams, B
    DIABETIC MEDICINE, 2002, 19 : 10 - 11
  • [30] Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia
    Inamoto, Sakiko
    Hayashi, Tetsuya
    Tazawa, Naoko
    Mori, Tatsuhiko
    Yamashita, Chika
    Nakano, Daisuke
    Matsumura, Yasuo
    Okuda, Nobuaki
    Sohmiya, Koichi
    Sakai, Akiko
    Furuya, Eisuke
    Kitaura, Yasushi
    CIRCULATION JOURNAL, 2006, 70 (06) : 787 - 792
12345